Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 25, 2001 - Issue 1
72
Views
14
CrossRef citations to date
0
Altmetric
Original

CLINICAL AND HEMATOLOGICAL RESPONSES TO HYDROXYUREA IN SICILIAN PATIENTS WITH Hb S/β-THALASSEMIA

, , , , &
Pages 9-17 | Received 19 Jul 2000, Accepted 19 Oct 2000, Published online: 07 Jul 2009

REFERENCES

  • Platt O. S., Brambilla D. J., Rosse W. F., Milner P. F., Castro O., Steinberg M. H., Klug P. P. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 1994; 330: 1639–1644
  • Charache S., Terrin M. L., Moore R. D., Dover G. J., Barton F. B., Eckert S. V., McMahon R. P., Bonds D. R. Multicenter study of hydroxyurea in sickle cell anemia: effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 1995; 332: 1317–1322
  • Scott J. P., Hillery C. A., Brown E. R., Misiewicz V., Labotka R. J. Hydroxyurea therapy in children severely affected with sickle cell disease. J. Pediatr. 1996; 128: 820–828
  • Rogers Z. R. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease. Semin. Hematol. 1997; 34: 42–47
  • Kinney T. R., Helms R. W., O’Branski E. E., Ohene-Frempong K., Wang W., Daeschner C., Vichinsky E., Redding-Lallinger R., Gee B., Platt O. S., Ware R. E. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Blood 1999; 94: 1550–1554
  • De Montalembert M., Belloy M., Bernaudin F., Gouraud F., Capdeville R., Mardini R., Philippe N., Jais J. P., Bardakdjian J., Ducrocq R., Maier-Redelsper-ger M., Elion J., Labie D., Girot R. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease. J. Pediatr. Hematol. Oncol. 1997; 19: 313–318
  • Claster S., Vichinsky E. First report of reversal of organ dysfunction in sickle cell anemia by use of hydroxyurea: splenic regeneration. Blood 1996; 88: 1951–1953
  • Voskaridou E., Kalotychou V., Loukopoulos D. Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle cell β-thalass-aemia. Br. J. Haematol. 1995; 89: 479–484
  • Johnson C. S., Omata M., Tong M. J., Simmons J. F., Jr., Weiner J., Tatter D. Liver involvement in sickle cell disease. Medicine (Baltimore) 1985; 64: 349–356
  • Schiliro G., Samperi P., Testa R., Gupta R. B., Gu L. H., Huisman T. H.J. Clinical, hematological, and molecular features in Sicilians with Hb S-β-thalassemia. Am. J. Hematol. 1992; 41(4)264–269
  • Noguchi C. T., Rodgers G. P., Serjeant G., Schechter A. N. Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N. Engl. J. Med. 1988; 318: 96–99
  • Rodgers G. P., Dover G. J., Noguchi C. T., Schechter A. N., Nienhuis A. W. Hematological responses in patients with sickle cell anemia treated with hy-droxyurea. N. Engl. J. Med. 1990; 322: 1037–1045
  • Schiliro G., Spena M., Giambelluca E., Maggio A. Sickle hemoglobinopathies in Sicily. Am. J. Hematol. 1990; 33(2)81–85
  • Maggio A., Castellano S. Antenatal diagnosis of β thalassaemia. Br. J. Haematol. 1984; 58: 202–203
  • Giambona A., Lo Gioco P., Marino M., Abate I., Di Marzo R., Renda M. C., Di Trapani F., Messana F., Siciliano S., Rigano P., Chehab F. F. The great heterogeneity of thalassemia molecular defects in Sicily. Hum. Genet. 1995; 95: 526–530
  • Roa D., Kopsombut P., Aguinaga M. P., Turner E. A. Hydroxyurea-induced denaturation of normal and sickle cell hemoglobins in vitro. J. Clin. Lab. Anal. 1997; 11: 208–213
  • Steinberg M. H., Nagel R. L., Brugnara C. Hydroxyurea independent of Hb F alters the erythrocytes of Hb SC disease. J. Invest. Med. 1996; 44: 233A
  • Steinberg M. H., Nagel R. L., Brugnara C. Cellular effects of hydroxyurea in Hb SC disease. Br. J. Haematol. 1997; 98: 838–844
  • Orringer P., Blythe S. B., Johnson A. E., Philips G., Dover G. J., Parker J. C. Effect of hydroxyurea on Hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia. Blood 1991; 78: 212–216
  • Adragna N. C., Fonseca P., Lauf P. K. Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells. Blood 1994; 83: 553–560
  • Styles L. A., Lubin B., Vichinsky E., Lawrence S., Hua M., Test S., Kuypers F. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea. Blood 1997; 89(7)2554–2559
  • Charache S., Barton F. B., Moore R. D., Terrin M. L., Steinberg M. H., Dover G. J., Ballas S. K., McMahon R. P., Castro O., Orringer E. P. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive “switching” agent. The multicenter study of hydroxyurea in sickle cell anemia. Medicine (Baltimore) 1996; 75: 300–326

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.